跳到主要导航 跳到搜索 跳到主要内容

HMGCL activates autophagy in osteosarcoma through β-HB mediated inhibition of the PI3K/AKT/mTOR signaling pathway

  • Wenda Liu
  • , Kezhou Xia
  • , Xinghan Huang
  • , Zhun Wei
  • , Zicheng Wei
  • , Xingyu Wang
  • , Chen Xiong
  • , Weichun Guo*
  • *此作品的通讯作者

科研成果: 期刊稿件 › 论文 › 同行评审

16 引用 (Scopus)

摘要

Background3-hydroxy-3-methylglutaryl-coenzymOHBe A(HMG-CoA) lyase (HMGCL) catalyzes the cleavage of HMG-CoA into acetyl-CoA and acetoacetic acid and serves as a rate-limiting enzyme in the metabolism of ketone bodies. While HMGCL is involved in various biological processes, its specific role in osteosarcoma remains unclear.MethodsUsing data from a public database of osteosarcoma patients, we investigated the expression and prognostic value of HMGCL. The effects of HMGCL on the proliferation, migration, and invasion of osteosarcoma cells were assessed using CCK-8 assays, wound healing tests, and transwell invasion assays. We explored and validated the specific molecular mechanisms by which HMGCL influences osteosarcoma through transcriptome sequencing. Finally, we established a subcutaneous tumor formation model in nude mice to investigate the function of HMGCL in vivo.ResultsThe expression of HMGCL is downregulated in osteosarcoma and correlates with the prognosis of osteosarcoma patients. Overexpression of HMGCL can inhibit the proliferation, migration, and invasion of osteosarcoma cells, as well as tumor growth in vivo. Through our investigation of the underlying mechanism, we found that HMGCL may inhibit the activation of the PI3K/AKT/mTOR signaling pathway via its product, beta-HB. This inhibition promotes the phosphorylation of ULK1, thereby facilitating autophagy in osteosarcoma cells and enhancing the malignancy of the disease.ConclusionHMGCL inhibits the activation of the PI3K/AKT/mTOR signaling pathway mediated by beta-HB, thereby reducing the proliferation, migration, and invasion of osteosarcoma cells while promoting autophagy. HMGCL may represent a new target for the treatment of osteosarcoma, offering new hope for patients with this disease.
源语言英语
期刊论文编号219
页数17
期刊JOURNAL OF TRANSLATIONAL MEDICINE
卷23
期1
DOI
出版状态已出版 - 21 2月 2025

基金资助

We sincerely thank the TCGA (https://portal.gdc.cancer.gov/) and GEO database (https://www.ncbi.nlm.nih.gov/geo/) for the use of their data.

关键词

  • Osteosarcoma
  • HMGCL
  • PI3K/AKT/mTOR signaling pathway
  • beta-HB
  • Autophagy

收录

  • SCIE
  • Scopus

学术指纹

探究 'HMGCL activates autophagy in osteosarcoma through β-HB mediated inhibition of the PI3K/AKT/mTOR signaling pathway' 的科研主题。它们共同构成独一无二的学术指纹。

引用此